abt

Abbott Laboratories Beats Estimates And Boosts Guidance

"abbott laboratories (business operation)", abt, nyse, earnings, eps, estimates, revenues, fiscal year, business, finance, investing, stock, news, trading, analysis, market

By FNNO Staff
fnnonline@gmail.com

Abbott Laboratories Tops Q2, Raises Full-Year Outlook

Published on Wed, 07/20/2011 - 08:35
By FNNO Staff in abbott laboratories, abt, analysis, business, earnings, eps, finance, market, news, stock, trading
abbott laboratories, abt, earnings, eps, business, finance, stock, trading, market, news, analysis

By FNNO Staff
fnnonline@gmail.com

Morning Market Snapshot: May 25, 2011

Published on Wed, 05/25/2011 - 09:11
By FNNO Staff in abt, amat, business, dtg, finance, htz, investing, mog, news, pay, spwra, stock, tot
htz, dtg, tot, spwra, amat, abt, pay, mog, business, finance, investing, stock, news

By FNNO Staff
fnnonline@gmail.com

Abbott Files For 510(k) Clearance For ARCHITECT 25-OH Vitamin D Assay

Published on Fri, 04/15/2011 - 11:10
By FNNO Staff in General Interest, abbott labs, abt, analysis, business, financial, market, news, stock, trading, News Update
abbott labs, abt, analysis, business, financial, market, news, stock, trading

Abbott Laboratories announced today that it has filed a submission for clearance from the U.S. Food and Drug Administration for a fully automated vitamin D assay performed on its widely used ARCHITECT testing system. The ARCHITE

By FNNO Staff
fnnonline@gmail.com

Sector Update: Health Care

abbott labs, abt, business, capsugel, cash, clinical, disease, drug, health, kohlberg kravis roberts, krr, medication, patient, pfe, pfizer, pharm, pill, revenue, sector, shares, treatment

Health care shares are trending higher, while Abbott Laboratories (ABT) is seeing solid gains after reporting study results. In sector news, Abbott Laboratories (ABT) today announced that data from its Endovascular Valve Edge-to-E

By FNNO Staff
fnnonline@gmail.com

Johnson & Johnson subsidiary confirms patent ruling against Abbott

abbott labs, abt, appeals, arthritis, award, bio, centocor ortho biotech, company, court, federal circuit, health, infringement, jnj, johnson & johnson, jury, law, lawsuit, legal, medical, patent, rheumatoid, ruling, tech, tnf, treatment, tumor, verdict, washington dc

Johnson & Johnson (JNJ) subsidiary Centocor Ortho Biotech received a decision from the Court of Appeals for the Federal Circuit in Washington, D.C. overturning a 2009 federal court jury verdict that awarded the company $1.8B a

By Mathieu Lloyd
mlloyd@fnno.com

Citigroup Downgraded Abbott Labs To Sell, Lowered Its PT To $44

Published on Thu, 01/27/2011 - 14:03
By Stephanie Shyu in Analyst reflections, abt, abbott laboratories, abt, analyst, citigroup, earnings, eps, financial news, investing, market analysis, stock, trading

The bank sees 2011 EPS of $4.52, vs. consensus estimates of $4.63 per share, and 2012 EPS of $4.68, vs. consensus estimates of $4.98 per share.

Abbott Laboratories has a potential upside of 23.6% based on a current price of $46.47 and an average consensus analyst price target of $57.42.

abbott laboratories, abt, analyst, citigroup, earnings, eps, financial news, investing, market analysis, stock, trading

Citigroup downgraded Abbott Laboratories (NYSE:ABT) to sell from hold and lowered its price target to $44 from $48.

By Stephanie Shyu
sshyu@fnno.com

What To Watch: January 26th, 2011

Published on Wed, 01/26/2011 - 11:30
By FNNO Staff in General Interest, abt, Analysis, BA, business, COP, ctrx, EK, Financial, Market, news, nflx, QCOM, SBUX, Stock, trading, UTX, WLP, xrx, abt, analysis, ba, business, cop, ctrx, ek, financial, market, news, nflx, qcom, sbux, stock, trading, utx, wlp, xrx
abt, analysis, ba, business, cop, ctrx, ek, financial, market, news, nflx, qcom, sbux, stock, trading, utx, wlp, xrx

Earnings season continues on in high gear on Wednesday with United Technologies, Abbott Laboratories, WellPoint, Eastman Kodak, Xerox, Boeing and ConocoPhillips all reporting before the market opens and Qualcomm, Netflix, Citrix,

By FNNO Staff
fnnonline@gmail.com

Abbott Labs Rises as RX Reported to Work Well in Less Risky Patients - Up 0.5%

Published on Mon, 01/24/2011 - 16:29
By Stephanie Shyu in News corner, abt, abbott laboratories, abt, business, higher, news, reuter, shares, stocks, trade, update

Abbott is looking to gain Food and Drug Administration approval to market the device to patients with a lower-risk profile.

Abbott shares are up 0.49%, or $0.24, to $48.16."

abbott laboratories, abt, business, higher, news, reuter, shares, stocks, trade, update

"Shares of Abbott Laboratories (ABT) are just higher following reports that its prescription Acculink carotid stent appears to work as well as surgery to open clogged neck arteries in pateients who are not at high risk for complic

By Stephanie Shyu
sshyu@fnno.com

DEPO Shares Continue to Drop Amidst Talks with Abbot

Published on Wed, 01/19/2011 - 10:27
By Stephanie Shyu in General Interest, abt, DEPO, abbott, abt, agreement, approval, depo, depomed, dispute, dm1796, drugs, fda, labs, license, shares

The dispute arose when ABT said it was reluctant to launch and commercialize DM-1796, an investigational, once-daily formulation of gabapentin for the management of post-herpetic neuralgia.

abbott, abt, agreement, approval, depo, depomed, dispute, dm1796, drugs, fda, labs, license, shares

Shares of DepoMed (DEPO) dropped as much as 13.37% to $5.70 in pre-market trading as the company tries to resolve its ongoing dispute with Abbott Laboratories (ABT) over the commercialization of its investigational drug DM-1796. T

By Stephanie Shyu
sshyu@fnno.com

Latest News from FNNO

Shares of Xylem Have Risen Above Previou...

Xylem (NYSE:XYL) traded at a new 52-week high today of $39.84. Approximately 892,000 s ...

Shares of Exxon Mobil Have Risen Above P...

Exxon Mobil (NYSE:XOM) traded at a new 52-week high today of $103.81. Approximately 11 ...

WR Berkley: The Winning Streak Continues...

WR Berkley (NYSE:WRB) traded today at a new 52-week high of $46.25. So far today appro ...

Westar Energy Looks to Continue to Trade...

Westar Energy (NYSE:WR) traded today at a new 52-week high of $37.40. Approximately 41 ...

WPX Energy Looks to Continue to Trade Ab...

WPX Energy (NYSE:WPX) traded today at a new 52-week high of $23.91. So far today appro ...

Whiting Petroleum: 52-Week High Recently...

Whiting Petroleum (NYSE:WLL) traded at a new 52-week high today of $80.86. This new hi ...

Recent 52-Week High Exceeded in Shares o...

Shares of Westmoreland Coal (AMEX:WLB) traded today at $37.10, breaking its 52-week hig ...

Recent 52-Week High Exceeded in Shares o...

Windstream (NASDAQ:WIN) traded today at a new 52-week high of $10.19. This new high wa ...

Most Popular Video News